Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells
Authors:
- Anling LiuALAnling Liu
- Bin LiuBLBin Liu
- Minghui LiMLMinghui Li
- Hailang YuHYHailang Yu
- Xiaojun LuoXLXiaojun Luo
- 1 November 2010
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 297 (1) , 117-125
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signalingOncogene, 2009
- Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring K-RAS MutationsCancer Research, 2009
- Nicotine Stimulates PPARβ/δ Expression in Human Lung Carcinoma Cells through Activation of PI3K/mTOR and Suppression of AP-2αCancer Research, 2009
- Molecular Basis of the Acceleration of the GDP-GTP Exchange of Human Ras Homolog Enriched in Brain by Human Translationally Controlled Tumor ProteinJournal of Biological Chemistry, 2009
- Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposideBlood, 2009
- Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung CancerMolecular & Cellular Proteomics, 2008
- Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic eventsGenes & Development, 2008
- Tumorigenic activity and therapeutic inhibition of Rheb GTPaseGenes & Development, 2008
- Constitutively active Rheb induces oncogenic transformationOncogene, 2008
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006